IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Drug Metabolism and Bioanalysis Letters

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

1.31

h-Index

2024-2025

 33

Rank

2024-2025

 15831

SJR

2024-2025

 0.326

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Drug Metabolism and Bioanalysis Letters
Abbreviation Drug Metab. Bioanal. Lett.
Publication Type Journal
Subject Area, Categories, Scope Biochemistry (medical) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4)
h-index 33
Overall Rank/Ranking 15831
SCImago Journal Rank (SJR) 0.326
Impact Score 1.31
Publisher Bentham Science Publishers
Country Netherlands
ISSN 29496810, 29496829
Best Quartile Q3
Coverage History 2022-2024




About Drug Metabolism and Bioanalysis Letters


Drug Metabolism and Bioanalysis Letters is a journal covering the technologies/fields/categories related to Biochemistry (medical) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4). It is published by Bentham Science Publishers. The overall rank of Drug Metabolism and Bioanalysis Letters is 15831. According to SCImago Journal Rank (SJR), this journal is ranked 0.326. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 33. The best quartile for this journal is Q3.

The ISSN of Drug Metabolism and Bioanalysis Letters journal is 29496810, 29496829. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Metabolism and Bioanalysis Letters is cited by a total of 78 articles during the last 3 years (Preceding 2024).


Drug Metabolism and Bioanalysis Letters Impact IF 2024-2025


The Impact IF 2024 of Drug Metabolism and Bioanalysis Letters is 1.31, which is computed in 2025 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Drug Metabolism and Bioanalysis Letters Impact IF 2025 Prediction


Impact IF 2024 of Drug Metabolism and Bioanalysis Letters is 1.31. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Drug Metabolism and Bioanalysis Letters. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 1.31

Drug Metabolism and Bioanalysis Letters h-index


  Table Setting

Drug Metabolism and Bioanalysis Letters has an h-index of 33. It means 33 articles of this journal have more than 33 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Drug Metabolism and Bioanalysis Letters ISSN


The ISSN of Drug Metabolism and Bioanalysis Letters is 29496810, 29496829. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Drug Metabolism and Bioanalysis Letters Rank and SCImago Journal Rank (SJR)


The overall rank of Drug Metabolism and Bioanalysis Letters is 15831. According to SCImago Journal Rank (SJR), this journal is ranked 0.326. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Drug Metabolism and Bioanalysis Letters by Year


Year SJR
2025/2026 Coming Soon
2024 0.326

Ranking of Drug Metabolism and Bioanalysis Letters by Year


Year Ranking
2025/2026 Coming Soon
2024 15831

Drug Metabolism and Bioanalysis Letters Publisher


Table Setting

Drug Metabolism and Bioanalysis Letters is published by Bentham Science Publishers. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2022-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Drug Metabolism and Bioanalysis Letters is Drug Metab. Bioanal. Lett.. This abbreviation ('Drug Metab. Bioanal. Lett.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Drug Metabolism and Bioanalysis Letters


If your research field is/are related to Biochemistry (medical) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Drug Metabolism and Bioanalysis Letters?

Drug Metabolism and Bioanalysis Letters latest impact IF is 1.31. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 1.31 (2024) and 1.31 (2024), respectively, in the last 1 year. Moreover, its average IS is 1.31 in the previous 1 year.


What's the SCImago Journal Rank (SJR) of the Drug Metabolism and Bioanalysis Letters?

The Drug Metabolism and Bioanalysis Letters has an SJR (SCImago Journal Rank) of 0.326, according to the latest data. It is computed in the year 2025. In the past 1 years, this journal has recorded a range of SJR, with the highest being 0.326 in 2024 and the lowest being 0.326 in 2024. Furthermore, the average SJR of the Drug Metabolism and Bioanalysis Letters over the previous 1-year period stands at 1.31.


What's the latest h-index of the Drug Metabolism and Bioanalysis Letters?

The latest h-index of the Drug Metabolism and Bioanalysis Letters is 33.


Who's the publisher of the Drug Metabolism and Bioanalysis Letters?

The Drug Metabolism and Bioanalysis Letters is published by the Bentham Science Publishers, with its country of publication being the Netherlands.


What's the current ranking of the Drug Metabolism and Bioanalysis Letters?

The Drug Metabolism and Bioanalysis Letters is currently ranked 15831 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 1 year, this journal has experienced varying rankings, reaching its highest position of 15831 in 2024 and its lowest position of 15831 in 2024.


What's the abbreviation or short name for the Drug Metabolism and Bioanalysis Letters?

The standard ISO4 abbreviation for the Drug Metabolism and Bioanalysis Letters is Drug Metab. Bioanal. Lett..


Is the "Drug Metabolism and Bioanalysis Letters" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Drug Metabolism and Bioanalysis Letters is classified as a journal that the Bentham Science Publishers publishes.


What's the scope or major areas of the Drug Metabolism and Bioanalysis Letters?

The Drug Metabolism and Bioanalysis Letters encompasses the following areas:

  • Biochemistry (medical)
  • Pharmaceutical Science
  • Pharmacology (medical)
  • Clinical Biochemistry

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Drug Metabolism and Bioanalysis Letters?

The Drug Metabolism and Bioanalysis Letters is assigned the following International Standard Serial Numbers (ISSN): 29496810, 29496829.


What's the best quartile of the Drug Metabolism and Bioanalysis Letters?

The best quartile for the Drug Metabolism and Bioanalysis Letters is Q3 (2024).


What's the coverage history of the Drug Metabolism and Bioanalysis Letters?

The Drug Metabolism and Bioanalysis Letters coverage history can be summarized as follows: 2022-2024.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Business: Theory and Practice journal 16073 Vilnius Gediminas Technical University 31 2.45
Statistica journal 18529 University of Bologna 9 0.38
Sapporo Medical Journal journal 29756 Sapporo Medical University 3 0.00
Journal of Imaging Science and Technology journal 22021 Society for Imaging Science and Technology 45 0.61
Journal of Medical Toxicology journal 5436 Springer New York 64 1.71
Geo-Info journal 30490 Nederlandse Vereniging voor Kartografie 2 0.00
International Journal of Organizational Analysis journal 6012 Emerald Group Publishing Ltd. 47 6.23
American Journal of Immunology (discontinued) journal 19764 Science Publications 12 1.56
Integrative Psychological and Behavioral Science journal 12203 Springer New York 44 1.59
Journal of Tropical Agriculture journal 25098 Kerala Agricultural University 21 0.26

Check complete list




Year wise Impact Score (IS) of Drug Metabolism and Bioanalysis Letters

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 1.31



Top Journals/Conferences in Biochemistry (medical)

Chem
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

MedComm
John Wiley and Sons Inc | United States

Apoptosis : an international journal on programmed cell death
Springer | United States

Journal of Clinical Endocrinology and Metabolism
Endocrine Society | United States

Translational Research
Elsevier Inc. | United States

Critical Reviews in Clinical Laboratory Sciences
Informa Healthcare | United Kingdom

EPMA Journal
BioMed Central Ltd | United Kingdom

Redox Report
Taylor and Francis Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmaceutical Science

Advanced Drug Delivery Reviews
Elsevier B.V. | Netherlands

Nano Today
Elsevier B.V. | Netherlands

Journal of Controlled Release
Elsevier B.V. | Netherlands

Advanced healthcare materials
John Wiley and Sons Inc | United States

Journal of Nanobiotechnology
BioMed Central Ltd | United Kingdom

Asian Journal of Pharmaceutical Sciences
Shenyang Pharmaceutical University | China

Apoptosis : an international journal on programmed cell death
Springer | United States

Phytomedicine
Elsevier GmbH | Germany

Bioengineering and Translational Medicine
John Wiley and Sons Inc | United States

Journal of Pharmaceutical Analysis
Xi'an Jiaotong University | China

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Clinical Biochemistry

Experimental and Molecular Medicine
Springer Nature | United Kingdom

Redox Biology
Elsevier B.V. | Netherlands

Biomarker Research
BioMed Central Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

Molecular Aspects of Medicine
Elsevier Ltd | United Kingdom

Angiogenesis
Springer Science and Business Media B.V. | Netherlands

Cell Chemical Biology
Elsevier Ltd | United Kingdom

Apoptosis : an international journal on programmed cell death
Springer | United States

Journal of Clinical Endocrinology and Metabolism
Endocrine Society | United States

Antioxidants and Redox Signaling
Mary Ann Liebert Inc. | United States

See All